1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,160 | 2,600 | 26.07. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Monogram Technologies Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.07. | Monogram Technologies Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.06. | Monogram Technologies Inc.: Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024 | 188 | ACCESSWIRE | Management to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram"... ► Artikel lesen | |
| 15.05. | Monogram Orthopaedics reports Q1 results | 1 | Seeking Alpha | ||
| 15.05. | Monogram Orthopaedics Inc.: Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies | 513 | ACCESSWIRE | New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position AUSTIN, TX / ACCESSWIRE / May 15, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the... ► Artikel lesen | |
| 14.05. | MONOGRAM ORTHOPAEDICS INC: Monogram Orthopaedics Reports First Quarter 2024 Financial Results | 303 | ACCESSWIRE | Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024Engaged Contract Research Organization to Oversee mBôs Robot... ► Artikel lesen | |
| 14.05. | MONOGRAM ORTHOPAEDICS INC - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | MONOGRAM ORTHOPAEDICS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | MONOGRAM ORTHOPAEDICS INC: Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S. | 481 | ACCESSWIRE | CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities AUSTIN, TX / ACCESSWIRE / May 13, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram"... ► Artikel lesen | |
| 01.05. | MONOGRAM ORTHOPAEDICS INC: Monogram Provides Regulatory Update Following Meeting with FDA | 379 | ACCESSWIRE | 510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics... ► Artikel lesen | |
| 01.05. | MONOGRAM ORTHOPAEDICS INC - 8-K, Current Report | 2 | SEC Filings | ||
| 18.04. | MONOGRAM ORTHOPAEDICS INC - 8-K, Current Report | - | SEC Filings | ||
| 11.04. | MONOGRAM ORTHOPAEDICS INC: Monogram Accepted to NVIDIA Inception Program | 534 | ACCESSWIRE | Collaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs SystemAUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM)... ► Artikel lesen | |
| 22.03. | Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 21.03. | PHIO and MGRM among healthcare movers | 4 | Seeking Alpha | ||
| 20.03. | MONOGRAM ORTHOPAEDICS INC: Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time | 219 | ACCESSWIRE | AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical... ► Artikel lesen | |
| 15.03. | Monogram Orthopaedics reports FY results | 2 | Seeking Alpha | ||
| 15.03. | MONOGRAM ORTHOPAEDICS INC: Monogram Orthopaedics Reports Full Year 2023 Financial Results | 362 | ACCESSWIRE | 510(k) Submission with FDA On Track for Second Half of 2024Shipped mBôs Surgical Robot System to First International CustomerIntroduced mVision Technologies, a Novel Approach to Registration and TrackingManagement... ► Artikel lesen | |
| 15.03. | MONOGRAM ORTHOPAEDICS INC - 8-K, Current Report | 2 | SEC Filings | ||
| 15.03. | MONOGRAM ORTHOPAEDICS INC - 10-K, Annual Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |
Das Unternehmen MONOGRAM TECHNOLOGIES INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +4,95 % bei einem Aktienkurs von 2,120 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MONOGRAM TECHNOLOGIES INC finden Sie auf Wallstreet Online.
